Today, the U.S. Food and Drug Administration proposed a new, risk-based enforcement approach to drug products labeled as homeopathic. To protect consumers who choose to use homeopathic products, this proposed new approach would update the FDA\u2019s existing policy to better address situations where homeopathic treatments are being marketed for serious diseases and\/or conditions but where the products have not been shown to offer clinical benefits. It also covers situations where products labeled as homeopathic contain potentially harmful ingredients or do not meet current good manufacturing practices.<\/p>\n","protected":false},"excerpt":{"rendered":"
Today, the U.S. Food and Drug Administration proposed a new, risk-based enforcement approach to drug products labeled as homeopathic. To protect consumers who choose to use homeopathic products, this proposed new approach would update the FDA\u2019s existing policy to better address situations where homeopathic treatments are being marketed for serious diseases and\/or conditions but where … Continue reading FDA proposes new, risk-based enforcement priorities to protect consumers from potentially harmful, unproven homeopathic drugs<\/span>